SignalUS

Drug shortage: Morphine Sulfate Injection (MORPHINE SULFATE, DURAMORPH, INFUMORPH 500)

FDA lists 24 presentations as Current. Availability: Unavailable (6), Limited Availability (2), Available (16). Reason: Discontinuation of the manufacture of the drug; Demand increase for the drug. Companies: Hospira, Inc., a Pfizer Company, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Piramal Critical Care Inc., Amphastar Pharmaceuticals, Inc..

Published by source
2017-10-31
First seen by Reality Radar
2026-10-22
Last verified
2026-10-30

Affected

Manufacturer
Hospira, Inc., a Pfizer Company
Products
Morphine Sulfate Injection MORPHINE SULFATE DURAMORPH INFUMORPH 500 MITIGO INFUMORPH 200

Whether your exact unit is affected depends on the model, serial number and region in the official notice.

What the official notice says

Risk: Current — Unavailable

Remedy / actions:

  • Discontinuation of the manufacture of the drug
  • Check wholesalers for inventory

Is this affecting you?

Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.

Track it free

Sources

Evidence ledger

Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.

EntryKindObservedEvidence hashEntry hash
#895new2026-10-226ac9d91d7bd6…c9a13d6bc5bce651f0…52c5af
#1128update2026-10-238bba8904d75d…9924cf75669bdca7f6…c00263
#1365update2026-10-23bbffe90d8652…6613f07d9b85339ee7…0b57d4
#2176update2026-10-27a0dfc79f0cc3…8d40c371946195ee5b…08f18f
#2445update2026-10-27cc3508b02873…2234df4189a13f213f…7511c1
#2552update2026-10-28eca7fa6b2640…bb9c0c7369c870e7b5…1bc45c
#2707update2026-10-28f504b491bd7d…84fc0ed38b0a41dd09…5f52c5
#2843update2026-10-296f95dc76e469…3ca568e6a0142851c5…fe010c
#3060update2026-10-303eb53b646e1e…1a3a8857031af45b53…ed6e63

Chain head: #3174 cbfa23d88c9b…201fc3

Raw ledger entries (JSON) · Verify chain

Share this signal